REPROCELL Research Development from 2010 to 2026

6RC Stock  EUR 0.57  0.00  0.00%   
REPROCELL's Research Development is increasing over the years with slightly volatile fluctuation. Research Development is expected to dwindle to about 466.5 M. During the period from 2010 to 2026 REPROCELL Research Development annual values regression line had geometric mean of  361,720,716 and mean square error of 9821.8 T. View All Fundamentals
 
Research Development  
First Reported
2019-03-31
Previous Quarter
98 M
Current Value
119.7 M
Quarterly Volatility
34.7 M
 
Covid
 
Interest Hikes
Check REPROCELL financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among REPROCELL's main balance sheet or income statement drivers, such as Net Interest Income of 81.4 M, Interest Income of 81.4 M or Interest Expense of 0.0, as well as many indicators such as . REPROCELL financial statements analysis is a perfect complement when working with REPROCELL Valuation or Volatility modules.
  
This module can also supplement various REPROCELL Technical models . Check out the analysis of REPROCELL Correlation against competitors.
Analyzing REPROCELL's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing REPROCELL's current valuation and future prospects.

Latest REPROCELL's Research Development Growth Pattern

Below is the plot of the Research Development of REPROCELL over the last few years. It is REPROCELL's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in REPROCELL's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

REPROCELL Research Development Regression Statistics

Arithmetic Mean385,829,240
Geometric Mean361,720,716
Coefficient Of Variation37.43
Mean Deviation126,275,694
Median276,449,000
Standard Deviation144,432,399
Sample Variance20860.7T
Range470.4M
R-Value0.75
Mean Square Error9821.8T
R-Squared0.56
Significance0.0006
Slope21,376,933
Total Sum of Squares333771.5T

REPROCELL Research Development History

2026466.5 M
2025617.3 M
2024536.8 M
2023385 M
2022501.5 M
2021535.3 M
2020662 M

About REPROCELL Financial Statements

REPROCELL stakeholders use historical fundamental indicators, such as REPROCELL's Research Development, to determine how well the company is positioned to perform in the future. Although REPROCELL investors may analyze each financial statement separately, they are all interrelated. For example, changes in REPROCELL's assets and liabilities are reflected in the revenues and expenses on REPROCELL's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in REPROCELL. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Research Development617.3 M466.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in REPROCELL Stock

REPROCELL financial ratios help investors to determine whether REPROCELL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REPROCELL with respect to the benefits of owning REPROCELL security.